Detalhe da pesquisa
1.
Design, synthesis and SAR of a novel series of benzimidazoles as potent NPY Y5 antagonists.
Bioorg Med Chem Lett
; 20(23): 7120-3, 2010 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20951033
2.
Discovery and structure-activity relationship of a novel spirocarbamate series of NPY Y5 antagonists.
Bioorg Med Chem Lett
; 20(20): 6103-7, 2010 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20813523
3.
Dihydropyrrole[2,3-d]pyridine derivatives as novel corticotropin-releasing factor-1 antagonists: mapping of the receptor binding pocket by in silico docking studies.
J Med Chem
; 51(22): 7273-86, 2008 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-18975927
4.
Synthesis and pharmacological characterization of novel druglike corticotropin-releasing factor 1 antagonists.
J Med Chem
; 51(23): 7370-9, 2008 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-18989952
5.
Cyclopenta[d]pyrimidines and dihydropyrrolo[2,3-d]pyrimidines as potent and selective corticotropin-releasing factor 1 receptor antagonists.
ChemMedChem
; 2(4): 528-40, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17335099
6.
Discovery process and characterization of novel carbohydrazide derivatives as potent and selective GHSR1a antagonists.
ChemMedChem
; 5(9): 1450-5, 2010 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-20593439
7.
Heteroaryl-substituted 4-(1H-pyrazol-1-yl)-5,6-dihydro-1H-pyrrolo[2,3-d]pyrimidine derivatives as potent and selective corticotropin-releasing factor receptor-1 antagonists.
ChemMedChem
; 3(2): 226-9, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18000940